Saluda Medical IncASX: SLD

Expands Access with Full US Commercial Release of CAP24

Oct 5, 2026 at 5:21 PM EDT · Issued by Saluda Medical Inc via ASX

Filed with ASX · Oct 5, 2026 at 5:21 PM EDT · 3 pages · English

On 6ix: 6ix.com/news/expands-access-with-full-us-commercial-release-of-cap24

Release

SALUDA MEDICAL, INC. ARBN 691 140 360 9401 James Ave S, Suite 132 Bloomington MN 55431, United States 1 ASX ANNOUNCEMENT 5 October 2026 Saluda Medical Expands Access to First and Only FDA-Approved Closed-Loop Surgical Paddle Lead with Full US Commercial Release of CAP24™ Saluda Medical, Inc....

Saluda Medical Inc on 6ix

Earlier from Saluda Medical

Initial Director's Interest NoticeSep 23
Director Appointment/ResignationSep 23
Final Director's Interest Notice - B ReganSep 13
FY26 Consolidated Financial StatementsSep 9
CEO TransitionSep 6

Later from Saluda Medical

Notification regarding unquoted securities - SLDOct 13
Notification of cessation of securities - SLDOct 13
Voluntary Field Action for Certain Evoke System DevicesOct 20
Notice of Annual Stockholders Meeting and CDI Voting FormOct 22
Annual Report to StockholdersOct 22

All Saluda Medical news releases

Follow Saluda Medical into a list and get an email when it puts out news.

Follow Saluda Medical